Literature DB >> 2817112

Use of medication and in vivo exposure in volunteers for panic disorder research.

C B Taylor1, R King, J Margraf, A Ehlers, M Telch, W T Roth, W S Agras.   

Abstract

A survey of 794 subjects volunteering for studies of panic disorder with or without phobic avoidance revealed that fewer than 15% had received imipramine and fewer than 15% had undergone in vivo exposure, although the majority had engaged in some form of counseling and had used benzodiazepines. Subjects with spontaneous panic attacks reported more avoidance than subjects with situational attacks. One-half of the subjects were unemployed. The authors recommend wider use of the available effective treatments for panic disorder and phobic avoidance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817112     DOI: 10.1176/ajp.146.11.1423

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

Review 1.  [Panic disorder and its psychological treatment].

Authors:  J Margraf; M Ruhmland
Journal:  Naturwissenschaften       Date:  1996-09

2.  Use of medical services and treatment for panic disorder with agoraphobia and for social phobia.

Authors:  R P Swinson; B J Cox; C B Woszczyna
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

Review 3.  Panic control treatment and its applications.

Authors:  S G Hofmann; D A Spiegel
Journal:  J Psychother Pract Res       Date:  1999

4.  What treatments do patients with panic disorder and agoraphobia get?

Authors:  B Bandelow; K Sievert; M Röthemeyer; G Hajak; E Rüther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

5.  Pharmacological management of panic disorder.

Authors:  Carlo Marchesi
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.